Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 1.

Journal Article

Javle, M., Kelley, R. K., Roychowdhury, S., Weiss, K. H., Abou-Alfa, G. K., Macarulla, T., Sadeghi, S., Waldschmidt, D., Zhu, A. X., Goyal, L., Borad, M., Yong, W. P., Borbath, I., El-Khoueiry, A., Philip, P., Moran, S., Ye, Y., Ising, M., Lewis, N. and Bekaii-Saab, T. (2018). Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions. Ann. Oncol., 29. S. 720 - 721. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

This list was generated on Thu Mar 28 15:33:37 2024 CET.